-
Therma Bright Portfolio Update: Inretio Successfully Completes First-in-Human Cohort for PREVA(TM) Stroke Platform; Targets 2026 U.S. FDA Trial
-
Therma Bright Sells an Additional 200-Units of Venowave(TM) to Strategic Distribution Partner Gen-X Med
-
Therma Bright Inc. Investee Company, InStatin Expands its Inhaled Statin Programs to include COPD (Chronic Obstructive Pulmonary Disease) as its Lead Indication.
-
Therma Bright adds healthcare veteran Raimondo to board
-
Therma Bright Appoints US Healthcare Veteran Michael Raimondo to the Board of Directors
-
Therma Bright Expands Relationship with Distribution Partner Gen-X Med for Venowave(TM) Sales
-
Therma Bright Proposes to Amend Certain Warrants
-
Therma Bright Announces Share Consolidation
-
Therma Bright Inc. Announces Share Consolidation
-
Therma Bright Proposes to Amend Certain Warrants and Negotiates Debt Settlements
-
Therma Bright Inc. Provides Update on InStatin Development, Announcement of Key Strategic Advisor and Highlights Preclinical and IP Progress at InStatin
-
Therma Bright Secures New Customer Initial Purchase Order, Signaling Market Confidence
-
Therma Bright Reviews Manufacturing Strategy in Light of US Tariff Changes
-
Therma Bright Secures an Initial Limited Exclusive U.S. Marketing and Distribution Contract for Its Consumer Products with Global Wellness Products LLC
-
Therma Bright Welcomes Healthcare and Technology Expert Steve Raysely to its Advisory Board
-
Therma Bright Secures Purchase Order For 1,750 Venowave W5 Units From National Distributor - DME Authority of Nashville, TN
-
Therma Bright Secures Purchase Order For Initial 100 Venowave Units From New National Distribution Partner - Valor Medical of San Antonio
-
Therma Bright Announces Shares for Debt Issuance
-
Therma Bright Announces Shares for Debt Issuance
-
Therma Bright Signs LOI For U.S. Distribution Network Expansion For Venowave With DME Authority
-
Therma Bright Congratulates Investment Partner Inretio's Promising Initial Results from PREVA(TM) Device's First Clinical Phase
-
Therma Bright's Distribution Partners Achieve 100% HCPCS Code Reimbursement In Under 60 Days
-
Therma Bright to Spin Off Consumer Product Portfolio to Create Two Publicly Traded Companies
-
Therma Bright Announces Shares for Debt Issuance
-
Therma Bright's Investment Partnership InStatin Joins Forces with InVixa to Enhance Its Patent Portfolio For The Development Of Innovative Respiratory Solutions
-
Therma Bright Announces Shares for Debt Issuance
-
Therma Bright Announces Quantify Medical as Nationwide U.S. Distribution Partner from August 22, 2024 Press Release
-
Therma Bright Announces Non-Brokered LIFE Financing & Concurrent Private Placement for up to a combined CAD$6 Million
-
Therma Bright Investment Portfolio Company InStatin Secures Mountain West Research Discovery Study Agreement
-
Therma Bright Announces Shares for Debt Issuance to Include Portfolio Company AI4LYF & IR Agreement
-
Therma Bright Welcomes Medical Device & Pharmaceutical Veteran Douglas S. Sommerville to Its Advisory Board
-
Therma Bright Congratulates John Patton, PhD of InStatin on Receiving the Prestigious Charles G. Thiel Award
-
Therma Bright Major Milestone: Portfolio Company Inretio's Preva(R) Device Achieves 3rd Human Trial Success
-
RETRANSMISSION: Therma Bright Secures Nationwide U.S. Distribution Partner For Venowave
-
Therma Bright Secures Nationwide U.S. Distribution Partner For Venowave
-
Therma Bright's Venowave VW5 Secures Permanent HCPCS Code E0683 from U.S. DHHS's Centers for Medicare & Medicaid Services
-
Therma Bright's AI-Powered Digital Cough Technology Being Considered as Partner Technology in New Chronic Cough Drug Clinical Trial
-
Therma Bright Welcomes Medical & Pharmaceutical Veteran Michael Raimondo to Its Advisory Board
-
Therma Bright Expands InStatin Investment
-
Therma Bright Receives Positive Notification from U.S. DHHS's Centers for Medicare & Medicaid (CMS)
-
Therma Bright's Venowave VW5 Secures FDA 510K Approval
-
Therma Bright Engages Independent Trading Group as Market Maker
-
Therma Bright Q2, 2024 Market Update On Business
-
Therma Bright Closes Second & Final Tranche of Fully Subscribed Non-Brokered Private Placement
-
Therma Bright Completes Debt Settlements
-
Therma Bright Closes $854,500 First Tranche of Non-Brokered Private Placement

